NIH-funded research R03 grant

Understanding how immune responses after a stroke can improve rehabilitation timing

Official title: Transcriptional Profiling of the Post-Stroke Immune Response to Tailor Rehabilitation Timelines

Funded at University of Maryland Baltimore · NIH-10813916 · Data updated 2026-11-12

This study is looking at how your immune system reacts after a stroke to help create a personalized recovery plan just for you, making sure your rehabilitation fits your unique healing journey.

More Stroke research and trials

Quick facts

Grant typeR03 grant
Study typeNIH-funded research
Funding institutionUniversity of Maryland Baltimore
NIH-funded
Lab location1 site (Baltimore, United States)
Project startFebruary 1, 2024
Project endJanuary 31, 2026
Funding year2024
Award (this year)$252,000
NIH project number1R03HD114143-01
Project IDNIH-10813916 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have recently experienced a stroke and are beginning their rehabilitation process.

Less likely to help

Patients who are not recovering from a stroke or those who are at a very advanced stage of recovery may not benefit from this research.

What this research studies

This research investigates how the immune response in the blood after a stroke can provide insights into the severity and progression of the condition. By analyzing the transcriptional profiles of immune cells, the study aims to develop a personalized approach to neurorehabilitation, tailoring rehabilitation programs to each patient's unique recovery timeline. The research combines expertise in stroke rehabilitation and genomics, utilizing advanced techniques to track immune responses over time. The goal is to enhance recovery outcomes by aligning rehabilitation efforts with biological markers of recovery.

Why it matters

Potential benefit: If successful, this research could lead to more effective and personalized rehabilitation strategies for stroke patients.

How similar studies have gone: Previous research has shown promise in using immune response markers to inform treatment timelines, suggesting that this approach could be effective.

Where this research is happening

  • University of Maryland Baltimore
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Braun, Robynne — University of Maryland Baltimore
  • Study coordinator: Braun, Robynne

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.